Evaluation of Safety and Efficacy of Virus Specific T-Cell Administration in Pediatric Patients With Systemic Viral Infection Following Allogeneic Hematopoietic Stem Cell Transplantation.

Abroad (travel likely)Recruiting

Conditions

BKV Infection · CMV Infection · EBV Infection

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The Catholic University of Korea Seoul St.Mary's Hospital, Seoul, South Korea
Contact: Principal Investigator (Jae-won Yoo, MD-PhD)

Study leads

Jae-won Yoo, MD-PhD
Principal Investigator
Department of Pediatrics, The Catholic University of Korea Seoul St.Mary's Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Evaluation of the Safety and Efficacy of LB-DTK-MV in Patients Diagnosed With Antiviral-Resistant CMV, BKV, or EBV Infection or Associated Diseases Following Anticancer Therapy or Allogeneic Hematopoietic Stem Cell Transplantation.

BKV Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Seoul, South Korea

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Pathogen Infection · EBV Infection · CMV Infection

Abroad (travel likely)RecruitingPHASE1, PHASE2

Shenzhen, China